Gemma Viñas

697 total citations
14 papers, 234 citations indexed

About

Gemma Viñas is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Gemma Viñas has authored 14 papers receiving a total of 234 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cancer Research, 6 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Gemma Viñas's work include Cancer, Lipids, and Metabolism (5 papers), Breast Cancer Treatment Studies (3 papers) and Global Cancer Incidence and Screening (2 papers). Gemma Viñas is often cited by papers focused on Cancer, Lipids, and Metabolism (5 papers), Breast Cancer Treatment Studies (3 papers) and Global Cancer Incidence and Screening (2 papers). Gemma Viñas collaborates with scholars based in Spain, United States and Palestinian Territory. Gemma Viñas's co-authors include Teresa Puig, Glòria Oliveras, Ariadna Giró‐Perafita, Ariadna Sarrats, Sònia Palomeras, David H. Lum, Alana L. Welm, Adriana Blancafort, María Buxó and Joan Dorca and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Gemma Viñas

14 papers receiving 231 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gemma Viñas Spain 7 165 140 66 36 11 14 234
Yassi Fallah United States 6 196 1.2× 123 0.9× 122 1.8× 35 1.0× 6 0.5× 7 309
Jiahuan Lu China 8 190 1.2× 128 0.9× 75 1.1× 47 1.3× 11 1.0× 21 304
Yannick Audet-Delage Canada 9 174 1.1× 132 0.9× 49 0.7× 20 0.6× 10 0.9× 13 266
Jie Qing Eu Singapore 6 206 1.2× 147 1.1× 76 1.2× 32 0.9× 12 1.1× 11 305
Tali Herzka United States 5 213 1.3× 95 0.7× 45 0.7× 59 1.6× 8 0.7× 5 265
Sameer H. Issaq United States 9 195 1.2× 152 1.1× 78 1.2× 48 1.3× 12 1.1× 11 299
Zhen Cai China 5 208 1.3× 146 1.0× 55 0.8× 33 0.9× 16 1.5× 9 285
Lavinia Insalaco Italy 12 229 1.4× 142 1.0× 112 1.7× 62 1.7× 7 0.6× 26 356
Jiaoyang Ning China 7 146 0.9× 69 0.5× 86 1.3× 47 1.3× 14 1.3× 11 277

Countries citing papers authored by Gemma Viñas

Since Specialization
Citations

This map shows the geographic impact of Gemma Viñas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gemma Viñas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gemma Viñas more than expected).

Fields of papers citing papers by Gemma Viñas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gemma Viñas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gemma Viñas. The network helps show where Gemma Viñas may publish in the future.

Co-authorship network of co-authors of Gemma Viñas

This figure shows the co-authorship network connecting the top 25 collaborators of Gemma Viñas. A scholar is included among the top collaborators of Gemma Viñas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gemma Viñas. Gemma Viñas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Navarro‐Sabaté, Àurea, Rebeca Font, Josep Alfons Espinàs, et al.. (2025). Evaluating the Quality of Real-World Data on Adherence to Oral Endocrine Therapy in Breast Cancer Patients: How Real Is Real-World Data?. Cancers. 17(2). 200–200. 1 indexed citations
2.
Felip, Eudald, Sònia Pernas, Gemma Viñas, et al.. (2024). Elderly patients with hormone receptor-positive HER2-negative metastatic breast cancer treated with CDK4/6 inhibitors in a multicentre cohort. Clinical & Translational Oncology. 26(7). 1748–1758. 2 indexed citations
3.
Clèries, Ramón, María Buxó, Mireia Vilardell, et al.. (2022). No Excess Mortality up to 10 Years in Early Stages of Breast Cancer in Women Adherent to Oral Endocrine Therapy: A Probabilistic Graphical Modeling Approach. International Journal of Environmental Research and Public Health. 19(6). 3605–3605. 1 indexed citations
4.
Clèries, Ramón, Alberto Ameijide, María Buxó, et al.. (2022). Ten-Year Probabilities of Death Due to Cancer and Cardiovascular Disease among Breast Cancer Patients Diagnosed in North-Eastern Spain. International Journal of Environmental Research and Public Health. 20(1). 405–405. 6 indexed citations
5.
Palomeras, Sònia, Ángel Díaz‐Lagares, Gemma Viñas, et al.. (2019). Epigenetic silencing of TGFBI confers resistance to trastuzumab in human breast cancer. Breast Cancer Research. 21(1). 79–79. 50 indexed citations
6.
Roca-Barceló, Aina, Gemma Viñas, Anna Carbó, et al.. (2018). Mortality of women with ductal carcinoma in situ of the breast: a population-based study from the Girona province, Spain (1994–2013). Clinical & Translational Oncology. 21(7). 891–899. 3 indexed citations
7.
Giró‐Perafita, Ariadna, Ariadna Sarrats, Glòria Oliveras, et al.. (2017). Fatty acid synthase expression and its association with clinico-histopathological features in triple-negative breast cancer. Oncotarget. 8(43). 74391–74405. 41 indexed citations
8.
Giró‐Perafita, Ariadna, Sònia Palomeras, David H. Lum, et al.. (2016). Preclinical Evaluation of Fatty Acid Synthase and EGFR Inhibition in Triple-Negative Breast Cancer. Clinical Cancer Research. 22(18). 4687–4697. 76 indexed citations
9.
Martı́n-Castillo, Begoña, Eugeni López‐Bonet, Elisabet Cuyàs, et al.. (2015). Cancer stem cell-driven efficacy of trastuzumab (Herceptin): towards a reclassification of clinically HER2-positive breast carcinomas. Oncotarget. 6(32). 32317–32338. 29 indexed citations
10.
Viñas, Gemma, Glòria Oliveras, Ariadna Giró‐Perafita, et al.. (2014). Triple Negative Breast Cancer: Clinicopathologic Characteristics and Fatty Acid Synthase (Fasn) Expression As a Potential Target. Annals of Oncology. 25. iv60–iv60. 2 indexed citations
11.
Porta, Rut, Adriana Blancafort, Joan Dorca, et al.. (2013). Fatty acid synthase expression is strongly related to menopause in early-stage breast cancer patients. Menopause The Journal of The North American Menopause Society. 21(2). 188–191. 13 indexed citations
12.
Viñas, Gemma, Teresa Puig, & Rut Porta. (2012). Estrés oxidativo en pacientes con cáncer: dos caras de una misma moneda. Medicina Clínica. 139(4). 171–175. 6 indexed citations
13.
Viñas, Gemma, Glòria Oliveras, Adriana Blancafort, et al.. (2012). Abstract P4-09-11: Fatty Acid Synthase (FASN) expression in Triple-Negative Breast Cancer. Cancer Research. 72(24_Supplement). P4–9. 3 indexed citations
14.
Brunet, Joan, Sonia Del Barco, Alexandra Garcia, et al.. (2006). Access to specialized cancer care and clinical trials for cancer patients from non-urban areas is facilitated by a Cancer Network organization. Journal of Clinical Oncology. 24(18_suppl). 16006–16006. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026